Beyond PD-1: CD96 is Becoming the Next "Battleground" in ImmunotherapyCD96 has emerged as a highly regarded immune checkpoint molecule in recent years, demonstrating increasing value in maintaining immune homeostasis and in disease treatment. This article systematically reviews the molecul...
Detailed information

Beyond PD-1/CTLA-4! The Emerging Immune Checkpoint CD160 is Transforming the Landscape of Tumor Immunotherapy1. What is CD160? CD160 is a membrane molecule closely associated with immune regulation, primarily distributed on immune cells such as NK cells, certain T cells, and intraepithelial lymphocytes. In rece...
Detailed information

The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune HomeostasisCD200 (also known as OX-2) is an important immunosuppressive molecule belonging to the immunoglobulin superfamily. It mediates negative immune regulation through binding to its receptor, CD200R, playing a critical role i...
Detailed information

CD74: From MHC II Chaperone to Therapeutic Target - Molecular Mechanisms, Disease Associations and Therapeutic AdvancesCD74 is the classic chaperone protein of major histocompatibility complex class II (MHC II) molecules and plays a key role in antigen presentation and adaptive immunity. Recent studies have shown that CD74 is also an imp...
Detailed information

Fibroblast Growth Factor 2 (FGF2): Molecular Mechanisms, Signaling Pathways, Disease Associations and Therapeutic AdvancesFibroblast growth factor 2 (FGF2) is a multifunctional growth factor widely involved in processes such as cell proliferation, angiogenesis, tissue repair, and tumor progression. This article systematically reviews the mo...
Detailed information

CD40LG: A Key Molecule in Immune Regulation, Disease Associations and Therapeutic ProgressCD40LG (CD154) is a key co-stimulatory molecule in the TNF superfamily, playing a central role in T cell-dependent B cell activation, antibody class switching, and immune memory formation. This article systematically rev...
Detailed information

CD19: Molecular Mechanisms, Disease Associations and Progress in Targeted TherapyCD19 is a critical molecule in B cell development and immune response, and has recently emerged as a core therapeutic target for B-cell malignancies and autoimmune diseases. This article systematically reviews the biolog...
Detailed information

CD33 (Siglec-3) Signaling Pathways and Disease Mechanisms: Roles in Acute Myeloid Leukemia, Alzheimer’s Disease and Immune RegulationCD33 (Siglec-3) is an important member of the Siglec family, primarily expressed on the surface of myeloid cells such as monocytes, macrophages, and dendritic cells. As an inhibitory immune receptor, CD33 mediates signal...
Detailed information

CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug DevelopmentCD4 is a key molecule on the surface of helper T cells and plays a central role in adaptive immune responses. This article systematically reviews the structure and function of CD4, the differentiation and regulatory mech...
Detailed information

BTN3A1 (CD277) Target: γδ T Cell Immune Recognition Mechanism and Cancer Immunotherapy Research ProgressBTN3A1 (also known as CD277) is a key molecule for human Vγ9Vδ2 T cells to recognize phosphoantigens (pAg), and an important node connecting metabolic abnormality sensing, immune activation and therapeutic translation....
Detailed information